Polymorphic ventricular tachycardia is an abnormal heart rhythm where the bottom chambers of your heart beat too quickly. People with severe cases may experience sudden cardiac arrest. Conditions that ...

As reviewed earlier, termination of reentrant tachycardia requires critical timing of the pacing stimulus. Success or failure of the pacing stimulus to interact with and terminate tachycardia, is ...

NEW ORLEANS – The Impella 5.0 and 5.5 left ventricular assist device failed to measure up on outcomes when used for high-risk patients undergoing ventricular tachycardia (VT) ablation therapies, ...

Ventricular tachycardia, or V-tach (VT), and supraventricular tachycardia (SVT) are two types of tachycardia. The term “tachycardia” refers to a heart rate of more than 100 beats per minute. The key ...

Solid Biosciences announces Phase 1b trial for SGT-501, a gene therapy for catecholaminergic polymorphic ventricular tachycardia, with FDA designations. Solid Biosciences Inc. has announced the ...

Recent advances have enabled noninvasive mapping of cardiac arrhythmias with electrocardiographic imaging and noninvasive delivery of precise ablative radiation with stereotactic body radiation ...

Much has been written on the potential dangers of sporting activities in children and young adults with potentially arrhythmogenic cardiac conditions. Current international guidelines recommend ...